4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-17-050016
Co-Chief Executive Officer bought 2,000 shares at $2.60 ($5,198)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WEST MICHAEL D Co-Chief Executive Officer | 2017-08-22 | Purchase | +2,000 | $2.60 | $5,198 | 882,864 | D: show line 1 in the form |
| Open-market purchases · 2,000 sh · avg $2.60 · $5,198 | |||||||
Loading xslF345X03/doc4.xml…